|
Volumn 66, Issue 3, 2012, Pages 511-513
|
Live attenuated varicella vaccine: A new effective adjuvant weapon in the battlefield against severe resistant psoriasis, a pilot randomized controlled trial
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
CHICKENPOX VACCINE;
CYCLOSPORIN;
PLACEBO;
SODIUM CHLORIDE;
VARICELLA ZOSTER VACCINE;
ADJUVANT THERAPY;
CELLULAR IMMUNITY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DISEASE SEVERITY;
DOWN REGULATION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
HUMAN;
HUMORAL IMMUNE DEFICIENCY;
IMMUNOCOMPETENCE;
IMMUNOSUPPRESSIVE TREATMENT;
LETTER;
LOW DRUG DOSE;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PILOT STUDY;
PRIORITY JOURNAL;
PSORIASIS;
RANDOMIZED CONTROLLED TRIAL;
REGULATORY T LYMPHOCYTE;
TH1 CELL;
TH17 CELL;
TH2 CELL;
TREATMENT DURATION;
UNSPECIFIED SIDE EFFECT;
VARICELLA ZOSTER VIRUS;
|
EID: 84857400753
PISSN: 01909622
EISSN: 10976787
Source Type: Journal
DOI: 10.1016/j.jaad.2011.07.032 Document Type: Article |
Times cited : (8)
|
References (6)
|